SCHEMBL8907138

SCHEMBL8907138

CN(C)C(=O)NCc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.52
CHRM2 P08172 1/20 0.51
CA2 P00918 1/20 0.51
EPHX1 P07099 1/20 0.51
GAA P10253 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
APOBEC3A P31941 1/20 0.50
APOBEC3G Q9HC16 1/20 0.50
MMP13 P45452 1/20 0.48
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1804701 0.81 NPC1 (0.58) L3MBTL1CHRM2CA2EPHX1GAA
SCHEMBL1521016 0.80 PTPRF (0.57) TSHRL3MBTL1CHRM2CA2EPHX1
SCHEMBL27968659 0.80 L3MBTL1 (0.57) TSHRL3MBTL1CHRM2CA2EPHX1
SCHEMBL6956941 0.79 KMT2A (0.56) L3MBTL1CHRM2CA2EPHX1MEN1
SCHEMBL14861111 0.79 GAA (0.58) TSHRL3MBTL1CA2EPHX1GAA
SCHEMBL2850347 0.79 APOBEC3A (0.58) L3MBTL1CA2EPHX1GAAMEN1
SCHEMBL4496741 0.79 MMP13 (0.59) L3MBTL1MEN1KMT2AMMP13
SCHEMBL13609107 0.78 CA2 (0.61) TSHRL3MBTL1CA2EPHX1GAA
SCHEMBL4587579 0.78 CA2 (0.58) TSHRL3MBTL1CHRM2CA2EPHX1
SCHEMBL4587574 0.78 CA2 (0.55) TSHRL3MBTL1CHRM2CA2EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997021666-A1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS GLAXO GROUP LIMITED (GB) 1997-06-19 WO disclosed